SCHEMBL2008660

SCHEMBL2008660

CC(O)C(=N)NS(=O)(=O)c1cccc(C(=O)C(C(=O)c2cc(F)cc(F)c2)=C2Nc3ccccc3N2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.34
KAT6A Q92794 2/20 0.34
GAA P10253 1/20 0.34
HTR2B P41595 1/20 0.34
MAPT P10636 1/20 0.33
F2 P00734 1/20 0.33
HDAC8 Q9BY41 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
NLRP3 Q96P20 2/20 0.32
LARS1 Q9P2J5 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
PRSS3 P35030 1/20 0.31
AKR1C3 P42330 1/20 0.31
KMT2A Q03164 1/20 0.31
ACLY P53396 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CASP6 P55212 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004811 0.95 KAT6A (0.39) HTTKAT6AGAAHTR2BMAPT
SCHEMBL2009835 0.87 KAT6A (0.35) HTTKAT6AGAAMAPTHDAC8
SCHEMBL2008888 0.86 GAA (0.37) KAT6AGAAMAPTAKR1C3KMT2A
SCHEMBL2008917 0.86 PTK2B (0.36) KAT6AMAPTACLY
SCHEMBL2009833 0.86 NLRP3 (0.36) HTTKAT6AGAAHTR2BMAPT
SCHEMBL2006900 0.85 KAT6A (0.38) KAT6AGAAMAPTF2HDAC8
SCHEMBL2007834 0.85 KAT6A (0.35) HTTKAT6AGAAMAPTF2
SCHEMBL2008403 0.84 KAT6A (0.37) KAT6AGAAMAPTF2HDAC8
SCHEMBL2006868 0.84 KAT6A (0.33) HTTKAT6AGAAMAPTAKR1C3
SCHEMBL2006932 0.84 AKR1C3 (0.37) KAT6AGAAMAPTF2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1864976-B1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-10-10 EP disclosed
US-7960562-B2 Propane-1,3-dione derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-06-14 US disclosed
US-20090181964-A1 Propane-1,3-Dione Derivative or Salt Thereof ASTELLAS PHARMA INC. 2009-07-16 US disclosed
EP-1864976-A1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181964-A1 Propane-1,3-Dione Derivative or Salt Thereof GNRHR, KISS1R, FSHR HTT 1214/4885KAT6A 3899/4885GAA 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.